Please assess the completion status of the following clinical trial:

Trial Title: Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age~* Capable of giving informed consents.~* Cases of NERD will be recruited on the basis of presence of heartburn and/or regurgitation using two validated GERD questionnaires in conjunction with an abnormal esophageal pH result and absence of erosions at standard endoscopy.~* Control subjects will include patients referred for an upper endoscopy for evaluation of non-reflux symptoms such as iron deficiency anemia, heme positive stools, screening of esophageal varices amongst others. A negative esophageal pH result and absence of erosions will be inclusion criteria for these patients.~Exclusion Criteria:~* Presence of macroscopic erosive esophagitis~* Pregnancy/lactation~* Chronic anticoagulation~* Patients with significant medical comorbidities (oxygen dependent chronic obstructive pulmonary disease, NYHA class III or IV congestive heart failure, recent diagnosis of cancer with a life-expectancy \< 5 years)~* History of Barrett's esophagus~* Presence of columnar lined distal esophagus on endoscopy with intestinal metaplasia~* Presence of cancer or mass lesion in the esophagus or stomach~* Esophageal strictures~* Peptic ulcer disease and Helicobacter pylori infection~* Prior history of esophageal surgery~* Allergic to PPIs~* Patients on drugs known to cause pill-related esophagitis (e.g. potassium supplements)~* Patients with HIV or other immunocompromised conditions who may have infectious esophagitis~* Eosinophilic esophagitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Esomeprazole (Type: ACTIVE_COMPARATOR): proton pump inhibitor
- Placebo (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).